Skip to main content
. Author manuscript; available in PMC: 2017 Sep 19.
Published in final edited form as: Cancer Detect Prev. 2005 Jan 28;29(1):59–65. doi: 10.1016/j.cdp.2004.10.002

Fig. 2.

Fig. 2

(A) Immunoblots of nuclear extracts from HNSCC cells probed with sera from patients with HNSCC and (B) with non-cancer control sera. Conditions related to primary and secondary antibodies were as in Fig. 1.